Primary experimental recordPositive observation

PMC12016742::ACT015708

Evidence text

Paper-level observation

the enhanced frequency of splenic CD4+ (P < 0.0001), CD8+ (P < 0.0001), and CD8+ IL2+ T cells (P < 0.0249), and CD8+/Treg ratio (P < 0.0001) (Figure S14d–g) compared to the other treated groups.

textConfidence: medium

Assay observation

Activity

Immunomodulatory

Subtype

Antibacterial

Measure

percent_inhibition

Comparator

Raw observation

P < 0.0249 vs other groups

Normalized measurement

<0.0249

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Mus musculus

Assay method

Not reported by source

Sequence

EGSRNQDWL

Standardization

ready simple

Source publication

Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma

Advanced Materials · 2025

DOI 10.1002/adma.202417348 PMC12016742

Parent mention

Related peptide identities

PEPDIA-PLP-000563

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.